Industry News
Shimadzu Opens New Solution Center in Maryland
Shimadzu's new Solution Center features additional research space.
Cytovance Biologics Expands GMP Warehouse and Manufacturing Operations
Cytovance Biologics continues to work on the expansion of a manufacturing operations and GMP warehousing facility in Oklahoma.
Aesica Appoints Commercial Managing Director
Aesica appoints Ian Muir to the newly created position of commercial managing director.
Sartorius Appoints New Head of Lab Products & Services Division
Sartorius appoints Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division.
FDA Outlines Agenda for New Guidances in 2014
FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.
Thermo Fisher Scientific Completes Acquisition of Life Technologies
Thermo Fisher Scientific outlines new business segments with acquisition of Life Technologies.
ISPE CEO to Step Down at End of 2014
International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.
EMD Millipore Expands its Emprove Raw Materials Portfolio
EMD Millipore's expands its Emprove raw materials portfolio to include 400 products.
PharmaCell to Purchase Cell Therapy Production Facility from TiGenix
PharmaCell enters an agreement purchase TiGenix therapy production facility.
Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing
Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.
FDA Prohibits Another Ranbaxy Facility from Producing Drugs for US Market
FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location
EMA Recommended 81 Medicines for Marketing Authorization in 2013
In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.
Stevens Institute of Technology Opens Biotechnology and Drug–Discovery Laboratory
The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.
Agilent Technologies, Picometrics Technologies to Offer CE–LIF–MS Systems
Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.
Novasep Appoints New President of Synthesis Business Unit
Novasep selects Thierry van Nieuwenhove as new president of the synthesis business unit.
Lonza Signs Agreement with Index Ventures for Biological Products
Lonza signs an agreement with Index Ventures for the development and manufacture of biologics for portfolio companies.
USP Inaugurates Expanded Shanghai Facility
USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.
CBR–SYNARC and BioClinica Merge And Appoint New Chairman
CCBR–SYNARC and BioClinica merge to create a provider of specialized outsourced clinical services.
Merck Recalls Cholesterol Medicine Due to Packaging Defect
A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.
CytomX Therapeutics and ImmunoGen to Develop Probody-Drug Conjugates
CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.
Eurofins Acquires the Discovery and Development Solutions Business of Merck KGaA
Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
LSNE Completes FDA Inspection
LSNE completes an FDA inspection of its Manchester manufacturing facility.Lyophilization Services of New England (LSNE),
Genzyme Receives Complete Response Letter from FDA on Lemtrada Application
Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.
Baxter Initiates Worldwide Voluntary Recall
Baxter International recalls dextrose injection and four sodium chloride injections.
Pall Corporation to Acquire ATMI's LifeSciences Business for $185 million
Pall Corporation, a solutions provider in filtration, separation and purification, has signed a definitive agreement with ATMI to acquire ATMI's LifeSciences business unit for $185 million.
Merck and GlaxoSmithKline Collaborate on Pazopanib
Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.
Bind, Amgen Amend Pact
Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.
CMC Biologics and OncoSynergy Form Pact
CMC Biologics and OnoSynergy form an agreement from cell-line development.
Pfizer Appoints Head of Vaccines
Pfizer appoints management changes to take effect in 2014.
